Journals of Gerontology Series A: Biological Sciences and Medical Sciences Large Type Edition
 QUICK SEARCH:   [advanced]
Year:  Vol:  Page: 

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Cited by other online articles
Google Scholar
Right arrow Articles by Khorram, O.
Right arrow Articles by Yen, S. S.
Right arrow Articles citing this Article
Right arrow PubMed Citation
Right arrow Articles by Khorram, O.
Right arrow Articles by Yen, S. S.

Journals of Gerontology Series A: Biological Sciences and Medical Sciences, Vol 52, Issue 1 M1-M7, Copyright © 1997 by The Gerontological Society of America


Activation of immune function by dehydroepiandrosterone (DHEA) in age- advanced men

O Khorram, L Vu and SS Yen
Department of Reproductive Medicine, University of California, San Diego School of Medicine, USA.

BACKGROUND: Substantial data from animal studies have demonstrated a stimulatory effect of dehydroepiandrosterone (DHEA) on immune function. However, little is known about the effects of DHEA on the human immune system. Since aging is associated with a decline in immune function and in DHEA production, we proposed that oral administration of DHEA to elderly men would result in activation of their immune system. METHODS: Nine healthy age-advanced men (mean age of 63 years) with low DHEA- sulfate levels participated in this study. They were treated nightly with an oral placebo for 2 weeks followed by DHEA (50 mg) for 20 weeks. Fasting (0800h-0900h) blood samples were obtained at 4- to 8-week intervals for immune function studies and hormone determinations. Freshly isolated peripheral lymphocytes were used for flow cytometric identification of lymphocyte subsets, cells expressing the IL-2 receptor (IL-2R), mitogen stimulation studies, and for determining natural killer (NK) cell number and cytotoxicity. Levels of interleukin- 2 (IL-2) and IL-6 secreted from cultured lymphocytes were determined under basal and mitogen stimulated conditions. Sera were analyzed for soluble IL-2 Receptor (sIL-2R) levels, insulin-like growth factor-I (IGF-I) and IGF binding protein-I (IGFBP-I) concentrations. RESULTS: Baseline levels of serum DHEA sulfate (DHEAS), a stable marker of circulating DHEA levels, were 2 standard deviations below young adult values and increased 3-4 fold within 2 weeks. These levels were sustained throughout the duration of DHEA administration. When compared with placebo, DHEA administration resulted in a 20% increase (p < .01) in serum IGF-I, a decreasing trend in IGFBP-I, and a 32% increase in the ratio of IGF-I/IGFBP-I (p < .01). Activation of immune function occurred within 2-20 weeks of DHEA treatment. The number of monocytes increased significantly (p < .01) after 2 (45%) and 20 (35%) weeks of treatment. The population of B cells fluctuated with increases (p < .05) at 2 (35%) and 10 (29%) weeks of treatment. B cell mitogenic response increased 62% (p < .05) by 12 weeks unaccompanied by changes in serum IgG, IgA, and IgM levels. Total T cells and T cell subsets were unaltered. However, a 40% increase (p < .05) in T cell mitogenic response, 39% increase in cells expressing the IL-2R (CD25+) (p < .05), and 20% increase in serum sIL-2R levels (p < .01) were found at 12-20 weeks of DHEA treatment, suggesting a functional activation of T lymphocytes occurred. In vitro mitogen stimulated release of IL-2 and IL-6 was enhanced 50% (p < .05) and 30% (p < .01) respectively by 20 weeks of treatment without basal secretion being affected. NK cell number showed a 22-37% increase (p < .01) by 18-20 weeks of treatment with a concomitant 45% increase (p < .01) in cytotoxicity. There were no adverse effects noted with DHEA administration. CONCLUSION: Administration of oral DHEA at a daily dose of 50 mg to age-advanced men with low serum DHEAS levels significantly activated immune function. The mechanism(s) to account for the immunoenhancing properties of DHEA are unclear. Consideration is given to the potential role of an increase in bioavailable IGF-I, which by virtue of its mitogenic effects on immune cell function, may mediate the DHEA effects. While extended studies are required, our findings suggest potential therapeutic benefits of DHEA in immunodeficient states.

This article has been cited by other articles: (Search Google Scholar for Other Citing Articles)

Home page
J Leukoc BiolHome page
E. Corsini, L. Vismara, L. Lucchi, B. Viviani, S. Govoni, C. L. Galli, M. Marinovich, and M. Racchi
High interleukin-10 production is associated with low antibody response to influenza vaccination in the elderly
J. Leukoc. Biol., August 1, 2006; 80(2): 376 - 382.
[Abstract] [Full Text] [PDF]

Home page
J Leukoc BiolHome page
E. Corsini, M. Racchi, E. Sinforiani, L. Lucchi, B. Viviani, G. E. Rovati, S. Govoni, C. L. Galli, and M. Marinovich
Age-related decline in RACK-1 expression in human leukocytes is correlated to plasma levels of dehydroepiandrosterone
J. Leukoc. Biol., February 1, 2005; 77(2): 247 - 256.
[Abstract] [Full Text] [PDF]

Home page
JAMAHome page
D. T. Villareal and J. O. Holloszy
Effect of DHEA on Abdominal Fat and Insulin Action in Elderly Women and Men: A Randomized Controlled Trial
JAMA, November 10, 2004; 292(18): 2243 - 2248.
[Abstract] [Full Text] [PDF]

Home page
J Am Coll NutrHome page
M. L. Kohut, J. R. Thompson, J. Campbell, G. A. Brown, M. D. Vukovich, D. A. Jackson, and D. S. King
Ingestion of a Dietary Supplement Containing Dehydroepiandrosterone (DHEA) and Androstenedione Has Minimal Effect on Immune Function in Middle-Aged Men
J. Am. Coll. Nutr., October 1, 2003; 22(5): 363 - 371.
[Abstract] [Full Text] [PDF]

Home page
J. Lipid Res.Home page
A. Khalil, J.-P. Fortin, J.-G. LeHoux, and T. Fülöp
Age-related decrease of dehydroepiandrosterone concentrations in low density lipoproteins and its role in the susceptibility of low density lipoproteins to lipid peroxidation
J. Lipid Res., October 1, 2000; 41(10): 1552 - 1561.
[Abstract] [Full Text]

All GSA journals The Gerontologist
Journals of Gerontology Series B: Psychological Sciences and Social Sciences
Copyright © 1997 by The Gerontological Society of America.